Blood lead in end-stage renal disease (ESRD) patients who were on maintainence haemodialysis

Journal of Clinical and Diagnostic Research

Volumn 6, Issue 10, 2012, Pages 1633-1635

  Subha Palaneeswari, M ^a   Abraham Sam Rajan, P M ^b   Silambanan, Santhi ^c   Jothimalar, ^c  

^a SREE BALAJI MEDICAL COLLEGE AND HOSPITAL   (India)

^b SAVEETHA MEDICAL COLLEGE AND HOSPITAL   (India)

^c SRI RAMACHANDRA UNIVERSITY   (India)

Author keywords

End stage renal disease; Lead; Maintenance haemodialysis

Indexed keywords

LEAD;

ADULT; ARTICLE; CONTROLLED STUDY; FEMALE; HEMODIALYSIS PATIENT; HUMAN; KIDNEY FAILURE; KIDNEY FUNCTION; LEAD BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; POPULATION RESEARCH; RANDOM SAMPLE; SMOKING; TREATMENT DURATION;

EID: 84871904932     PISSN: 2249782X     EISSN: 0973709X     Source Type: Journal    
DOI: 10.7860/JCDR/2012/4856.2627     Document Type: Article

References (19)

1. Braunwald, Fauci, Kasper, Hauser, Longo, Jameson. Disturbances of the renal function. In: Harrison's Principles of Intenal Medicine (15th ed). Mc Graw Hill Medical Publishing division. 2004;2:1535-41.
2. Vanholder R, Cornelis R, Dhondt A, et al. The role of trace elements in the uremic toxicity. Nephrol Dial Transplant. 2002;17(2): 2-8.
3. Vanholder R, Cornelis R, Dhondt A, et al. The trace element metabolism in renal disease. In: Kopple J. Massry SG, eds. The Nutritional Management of Renal Disease. Williams and Eilkins. Baltimore. 1996; 395-414.
4. Soderland P, Loverkar S, Weiner DE et al. Chronic kidney disease which is associated with environmental toxins and exposures. Advances in Chronic Kidney Disease. 2010; 17(3): 254-64.
5. Lin JL, Tan DTL, Hsing K, Chen et al. The blood lead levels which are associated with an 18-month all-cause mortality in patients with chronic peritoneal dialysis. Nephrol Dial Transplant. 2010; 25:1627-33.
6. Krachler M, Wirnsberger G, Irgolic KJ. The trace element status of hemodialysis patients. Boil trace Elem Res. 1997;58:209-21.
7. Martegani M, Gobba F, Fratini G, et al. Does a lead overload develop in hemodialysis patients. Nephron 1989;51:420-42.
8. Winterberg B, Fischer R, Dorst KG, et al. The bone lead and the bone aluminium at various stages of renal insufficiency. Nieren-u. Hochdruckkr. 1989;18:249-53.
9. Chen B, Lamberts LV et al. The selenium, lead, and the cadmium levels in renal failure patients in China. Biol Trace Elem Res. 2009;131(1):1-12.
10. Lee SH, Huang JW, Hung KV, et al. The trace metals abnormalities in hemodialysis patients; their relationship with the medications. Artificial Organs. 2000;24(11):841-44.
11. Ferraro et al. A low level exposure to cadmium increases the risk of chronic kidney disease: analysis of the NHANES study,1999-2006. BMC Public Health. 2010; 10: 304: 1471-2458.
12. Lee TH, Tseng MC, Chen CJ, et al. Association of the high body lead store with severe intracranial caroatiad atherosclerosis. Neurotoxicity. 2009; Nov;30(6):876-80.
13. Colleoni N, Arrigo G, Gandini E, et al. The blood lead in hemodialysis patients. Am J Nephrol. 1993;13:198-202.
14. Kessler M, Durand PV, Huu TC, et al. Mobilization of lead from the bone in end-stage renal failure patients with secondary hyperparathyroidism. Nephrol dial Transplant. 1999;14:2731-33.
15. Muntner P, Menke A, Batuman V et al. Association of the tibia lead and the blood lead with end-stage renal disease: a pilot study on African-Americans. Environ Res. 2007;104:396-401.
16. Lustberg M, Silbergeld E. The blood lead levels and the mortality. Arch Intern Med. 2002;162:2443-49.
17. Schober SE, Mirel LB, Graubard BI et al. The blood lead levels and the death due to all causes, cardiovascular diseases, and cancer: results from the NHANES III mortality study. Environ Health Perspect. 2006;114:1538-41.
18. Menke A, Muntner P, Batuman V et al. The blood levels of lead below 0.48 micromol. L (10 microg/dL) and the mortality among US adults. Circulation. 2006;114:1388-94.
19. Lin JL, Lin-Tan DT, Hsu KH, Environmental lead exposure and the progression of chronic renal diseases in patients without diabetes. New England journal of medicine. 2003;348(4):277-86.